What must research ethics committees in the host country do when placebo-controlled trials are planned?

a) Negotiate drug prices for established treatments
b) Assess or seek expert opinion on whether the results are responsive to the needs of the country
c) Request for a non-inferiority design comparing the intervention with the established method.
d) Only assess scientific and technical aspects of the protocol